We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Toolkit and case studies to support those looking at alternative delivery models for their library services.
Investors and businesses may be legally required to tell the government about certain sensitive acquisitions under the National Security and Investment Act.
Employment Appeal Tribunal Judgment of Mrs Justice Eady on 3 May 2024.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Pharmacy, prescription-only (POM), and general sale list (GSL) medicines: apply to move your medicine to a different classification.
When tests to detect COVID-19 are commonly used (use cases) and what to consider when deciding which type of test to employ.
The UK government's design principles and examples of how they've been used.
How to use a quasi-experimental study to evaluate your digital health product.
MSF 4258 provides an alternative route for the revalidation of a certificate of competency.
Guidance for the pharmaceutical industry on Marketing Authorisations for veterinary medicines.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Guidance for the pharmaceutical industry on how to apply to vary a veterinary Marketing Authorisation (MA) or Homeopathic Remedy.
Find out how to report information to HMRC using the Automatic Exchange of Information (AEOI) if you are a financial institution.
The MHRA has authorised cabotegravir as 30 mg tablets and as a 600 mg long-acting injection administered every two months
How the TRA will conduct new investigations and reviews of existing anti-dumping and countervailing measures.
How Business e-services customers can register standard restrictions on e-RX1 through the portal.
Guidance on the use of Habitats Regulations Assessment
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.